PURE Bioscience (OTCMKTS:PURE – Get Free Report) was the recipient of a significant drop in short interest in the month of October. As of October 30th, there was short interest totaling 1,982 shares, a drop of 54.8% from the October 15th total of 4,381 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 26,909 shares, the short-interest ratio is presently 0.1 days.
PURE Bioscience Trading Down 14.3%
Shares of PURE traded down $0.01 during mid-day trading on Monday, hitting $0.06. The company’s stock had a trading volume of 38,070 shares, compared to its average volume of 31,520. PURE Bioscience has a 1-year low of $0.04 and a 1-year high of $0.10. The firm has a 50-day simple moving average of $0.07 and a 200 day simple moving average of $0.07. The firm has a market capitalization of $7.80 million, a P/E ratio of -3.00 and a beta of 0.34.
About PURE Bioscience
See Also
- Five stocks we like better than PURE Bioscience
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
